51
Participants
Start Date
December 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Control
In the control condition, participants will purchase tobacco/nicotine products in the ETM. Cigarettes will increase in price across trials.
Product Category Score
In the product category score condition, participants will purchase tobacco/nicotine products in the ETM where the percentage of taxes applied to each product category will be distributed between 0% and 100% proportional to their abuse liability score. Abuse liability scores will be scaled such that the product category with the highest abuse liability will be taxed at 100%.
Product Category Rank
In the product category rank condition, participants will purchase tobacco/nicotine products in the ETM where the tax percentage applied to each product category will be determined by the number of categories and their position in the ranking. The product category with the highest abuse liability will be taxed at 100%; the product with the lowest abuse liability will be taxed at 0%. All other tax rates will be equally spaced across other products based on ranking.
Product Tiers
In the product tiers condition, participants will purchase tobacco/nicotine products in the ETM where tobacco products will be placed in tax tiers to simplify the existing complex tobacco tax system. The investigators will use three tax tiers (i.e., high tax, medium tax, and no tax), as adopted by four states. Products will be placed into tiers depending on their average score (i.e. no tax: \< 0.33, medium tax: 0.33-0.66, and high tax: \>0.66). Products in the high tax tier will be taxed at 100% and products in the medium tax tier will be taxed at 50%.
Fralin Biomedical Research Institute at VTC, Roanoke
National Cancer Institute (NCI)
NIH
National Institutes of Health (NIH)
NIH
Virginia Polytechnic Institute and State University
OTHER